Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Cash from Investing Activities (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Cash from Investing Activities for 6 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 97.1% year-over-year to -$1.8 million, compared with a TTM value of $10.1 million through Dec 2025, up 112.19%, and an annual FY2025 reading of $10.1 million, up 112.19% over the prior year.
  • Cash from Investing Activities was -$1.8 million for Q4 2025 at Cytek Biosciences, down from $18.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $43.1 million in Q3 2023 and bottomed at -$168.9 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is -$12.2 million, with a median of -$1.3 million recorded in 2021.
  • Peak annual rise in Cash from Investing Activities hit 3849.91% in 2023, while the deepest fall reached 21550.51% in 2023.
  • Year by year, Cash from Investing Activities stood at -$18.3 million in 2021, then tumbled by 179.1% to -$51.1 million in 2022, then soared by 156.92% to $29.1 million in 2023, then tumbled by 318.24% to -$63.4 million in 2024, then skyrocketed by 97.1% to -$1.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CTKB at -$1.8 million in Q4 2025, $18.9 million in Q3 2025, and -$16.4 million in Q2 2025.